Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Endobronchial Ultrasound Transbronchial Needle Guided Interstitial Photodynamic Therapy for Palliation of Locally Advanced Lung Cancer and Advanced Cancers Obstructing the Airway -Phase I/II

Next Previous
Trial Profile

Endobronchial Ultrasound Transbronchial Needle Guided Interstitial Photodynamic Therapy for Palliation of Locally Advanced Lung Cancer and Advanced Cancers Obstructing the Airway -Phase I/II

Status: Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 21 Apr 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Porfimer sodium (Primary)
  • Indications Non-small cell lung cancer; Small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use

Most Recent Events

  • 16 Apr 2025 Status changed from active, no longer recruiting to discontinued. Reason the study was stopped: was paused by device company for a long period of time.
  • 01 Aug 2024 Status changed from recruiting to active, no longer recruiting.
  • 01 Jun 2023 Planned number of patients changed from 36 to 65.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top